(Q44968030)

English

Retrospective analysis of the efficacy and safety of once-daily tadalafil in patient subgroups: men with mild vs moderate ED and aged <50 vs 50 years

scientific article published on 6 December 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 December 2017

Retrospective analysis of the efficacy and safety of once-daily tadalafil in patient subgroups: men with mild vs moderate ED and aged <50 vs 50 years (English)

1 reference

Europe PubMed Central

7 December 2017

author name string

A D Seftel

1

1 reference

Europe PubMed Central

7 December 2017

R Shinghal

2

1 reference

Europe PubMed Central

7 December 2017

E D Kim

3

1 reference

Europe PubMed Central

7 December 2017

S M Samuels

4

1 reference

Europe PubMed Central

7 December 2017

X Ni

5

1 reference

Europe PubMed Central

7 December 2017

P R Burns

6

1 reference

Europe PubMed Central

7 December 2017

publication date

6 December 2012

1 reference

Europe PubMed Central

7 December 2017

International Journal of Impotence Research

1 reference

Europe PubMed Central

7 December 2017

25

1 reference

Europe PubMed Central

7 December 2017

91-98

1 reference

Europe PubMed Central

7 December 2017

3

1 reference

Europe PubMed Central

7 December 2017

https://scigraph.springernature.com/pub.10.1038/ijir.2012.40

0 references

The prevalence of erectile dysfunction in the primary care setting: importance of risk factors for diabetes and vascular disease

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.40

21 January 2018

Prevalence and correlates of erectile dysfunction by race and ethnicity among men aged 40 or older in the United States: from the male attitudes regarding sexual health survey

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.40

21 January 2018

Prevalence of erectile dysfunction among young adults: results of a large-scale survey

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.40

21 January 2018

Sexual dysfunction in the United States: prevalence and predictors

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.40

21 January 2018

Drivers and barriers to seeking treatment for erectile dysfunction: a comparison of six countries.

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.40

21 January 2018

The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population.

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.40

21 January 2018

Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'.

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.40

21 January 2018

Management of erectile dysfunction in diabetes: an update for 2008.

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.40

21 January 2018

Sexual function in men older than 50 years of age: results from the health professionals follow-up study

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.40

21 January 2018

Is the metabolic syndrome an independent risk factor for erectile dysfunction?

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.40

21 January 2018

The efficacy and safety of tadalafil: an update

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.40

21 January 2018

Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.40

21 January 2018

Aging and sexual response in the laboratory in patients with erectile dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.40

21 January 2018

Tadalafil pharmacokinetics in healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.40

21 January 2018

Tadalafil once daily in the management of erectile dysfunction: patient and partner perspectives

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.40

21 January 2018

Improvements in confidence, sexual relationship and satisfaction measures: results of a randomized trial of tadalafil 5 mg taken once daily.

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.40

21 January 2018

Impact on erectile function and sexual quality of life of couples: a double-blind, randomized, placebo-controlled trial of tadalafil taken once daily.

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.40

21 January 2018

Safety, efficacy, and pharmacokinetic overview of low-dose daily administration of tadalafil.

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.40

21 January 2018

Daily patterns of sexual intercourse attempts by men with erectile dysfunction treated with tadalafil: influence of age and marital status.

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.40

21 January 2018

Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5mg and 10mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.40

21 January 2018

Tadalafil dosed once a day in men with erectile dysfunction: a randomized, double-blind, placebo-controlled study in the US.

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.40

21 January 2018

The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction.

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.40

21 January 2018

Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function.

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.40

21 January 2018

Vardenafil is effective and well-tolerated for treating erectile dysfunction in a broad population of men, irrespective of age.

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.40

21 January 2018

Sildenafil for male erectile dysfunction: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.40

21 January 2018

Minimal clinically important differences in the erectile function domain of the International Index of Erectile Function scale.

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.40

21 January 2018

Tadalafil is efficacious and well tolerated in the treatment of erectile dysfunction (ED) in men over 65 years of age: results from Multiple Observations in Men with ED in National Tadalafil Study in the United States

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.40

21 January 2018

Efficacy and safety of tadalafil across ethnic groups and various risk factors in men with erectile dysfunction: Use of a novel noninferiority study design

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.40

21 January 2018

Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.40

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiology of erectile dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.40

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of erectile dysfunction and associated factors among men without concomitant diseases: a population study

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.40

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of prevalence between self-reported erectile dysfunction and erectile dysfunction as defined by five-item International Index of Erectile Function in Taiwanese men older than 40 years

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.40

7 January 2021

based on heuristic

inferred from DOI database lookup

Penile and finger sensory thresholds in young, aging, and diabetic males

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.40

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of tadalafil once daily: considerations for the practical application of a daily dosing option

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2012.40

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/IJIR.2012.40

1 reference

Europe PubMed Central

7 December 2017

1 reference

Europe PubMed Central

7 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44968030&oldid=2059845740"